Bank Of America Corp Incyte Corp Put Options Transaction History

Bank Of America Corp

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	SELL	$60.95 - $75.51 $3.58 Million - $4.43 Million	-58,700 Reduced 99.49%	300 $18,000
Q1 2023 May 12, 2023	BUY	$70.23 - $86.01 $4.12 Million - $5.05 Million	58,700 Added 19566.67%	59,000 $4.26 Million
Q3 2022 Nov 14, 2022	SELL	$66.18 - $82.86 $1.97 Million - $2.46 Million	-29,700 Reduced 99.0%	300 $20,000
Q2 2022 Aug 12, 2022	BUY	$66.18 - $83.18 $1.99 Million - $2.5 Million	30,000 New	30,000 $0

635

193M

763K

476K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $17.9B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.